Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{ca19be29e1254843b07138f366645526,

title = "Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market",

author = "Almeter, \{Philip J.\} and Hessel, \{Eugene A.\} and Labuhn, \{Jonathan A.\} and Morris, \{Peter E.\}",

year = "2019",

month = apr,

doi = "10.1213/ANE.0000000000004042",

language = "English",

volume = "128",

pages = "E55--E56",

number = "4",

}

TY - JOUR

T1 - Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market

AU - Almeter, Philip J.

AU - Hessel, Eugene A.

AU - Labuhn, Jonathan A.

AU - Morris, Peter E.

PY - 2019/4

Y1 - 2019/4

UR - https://www.scopus.com/pages/publications/85063260679

UR - https://www.scopus.com/pages/publications/85063260679#tab=citedBy

U2 - 10.1213/ANE.0000000000004042

DO - 10.1213/ANE.0000000000004042

M3 - Letter

C2 - 30730466

AN - SCOPUS:85063260679

SN - 0003-2999

VL - 128

SP - E55-E56

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

IS - 4

ER -